c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
about
Mechanism of ASC-mediated apoptosis: bid-dependent apoptosis in type II cellsLymphoma: immune evasion strategiesTargeting NF-kappaB in hematologic malignanciesHodgkin lymphoma: an update on its biology with new insights into classification.FLIP protects against hypoxia/reoxygenation-induced endothelial cell apoptosis by inhibiting Bax activationTrypanosoma cruzi posttranscriptionally up-regulates and exploits cellular FLIP for inhibition of death-inducing signal.c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cellsParthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway.Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma.The role of cellular FLICE inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer.A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase.The role of c-FLIP splice variants in urothelial tumours.Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.Intracellular localization map of human herpesvirus 8 proteins.Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.Novel therapies for Hodgkin Lymphoma.A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.Apoptosis pathways as promising targets for skin cancer therapy.Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.FLIP as an anti-cancer therapeutic target.Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia.CD30: an important new target in hematologic malignancies.Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines).Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas.Carbon monoxide inhibits Fas activating antibody-induced apoptosis in endothelial cells.Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell linesProcaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing.Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells.CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells.Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis.Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis.The proteasome is required for rapid initiation of death receptor-induced apoptosis
P2860
Q24302312-BDDEC299-2521-404E-BBC1-10DBB3B9CDADQ28080705-06217A49-09CA-4EAE-8C3D-0A5556E67C9BQ28299055-51E18211-BB6E-4378-99F4-6C8ED1AD8D0EQ33588862-B01F6D7F-8C8F-49B1-B132-B3EB27DB6A40Q33837045-89F961E8-532C-4ECE-9B7C-2023C8CB3F64Q33911077-AD73462B-1DC0-49AB-9BB1-A81AB289DD1BQ34139663-FBD4BF73-A213-446A-AB3E-361129299E40Q34378553-C9DD9817-178E-456D-BB00-71815A9FC696Q34427649-5498E35C-46BD-480F-A0A6-5264DD071D1EQ34480682-BE3E1285-6CAD-4EB7-83F8-7E25E57827F2Q34488806-50E538DF-945A-4B92-801C-19BB2FD68B9FQ35038107-D053819F-60DA-4E29-8BE5-95BBB14C835CQ35657114-EFD130BD-BB51-4F5C-A2F3-A56374ED4341Q35762274-F24CD727-5F24-4753-8ED5-DB97B0F71DFEQ35915103-FEADCACB-E2BC-4713-8DD1-98EDBD2ABF51Q36033375-D986E3F8-AC12-4B21-9D18-22B13C7264D1Q36483264-4E8EBA35-D9D7-45D8-9D0B-510C2B18DD91Q36500552-FCA744F9-E65E-4CBC-A963-868FC72769E7Q36612532-F40FB3F3-0BB7-420A-ABC4-E317B32EF188Q36694809-9F728291-25EE-432A-94A5-3764FE130C2CQ36815310-06C75372-CAF7-40A9-A04F-94BE3B909F30Q37016499-203C6014-0B0F-45C9-8F7A-0C375F9CA441Q37096732-A671BAD0-93F4-4E4C-8622-3258F53A441AQ37271829-09EDC8A4-3C95-4C4B-82D5-83957BBBE2DDQ37374435-19D36616-6830-4453-8186-F1447F581EE7Q37790694-DAF363FD-62AF-48E5-BF13-411F6655D986Q37880873-028C7796-6FA1-4135-98B8-F20C3AB40721Q38217477-A1F9B67E-8B62-4880-BD76-A1F491C13D91Q39467184-08CF0AED-478B-4C58-B193-1539A4D06F92Q39636596-719F99B1-148D-4324-9099-C06588EF4128Q39774985-FD8C41C3-2CEE-47A0-BE1D-2021F44DE1D9Q39835258-96129504-7155-487A-8A2C-5D65070BD771Q39935218-A85CA9EB-587F-4F39-B446-4D7BAC8A122FQ40026531-86E74625-ADC5-4C57-BA4A-C5DC74552F28Q40169298-8DC4BB69-1412-4587-8F3C-D554A6488959Q40200306-114763AB-67E0-4198-9DC4-631A9C4DB133Q40337542-7AD621B0-171F-4331-B6CE-B02A91646866Q40421605-A9BD3F06-8C66-45DF-8660-447B3436A7F7Q40448034-F79F9DAB-F058-4449-BAD1-6C0E55C82BD1Q42046723-9149BECA-C586-4740-8986-9B961A522899
P2860
c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
c-FLIP mediates resistance of ...... th receptor-induced apoptosis.
@ast
c-FLIP mediates resistance of ...... th receptor-induced apoptosis.
@en
type
label
c-FLIP mediates resistance of ...... th receptor-induced apoptosis.
@ast
c-FLIP mediates resistance of ...... th receptor-induced apoptosis.
@en
prefLabel
c-FLIP mediates resistance of ...... th receptor-induced apoptosis.
@ast
c-FLIP mediates resistance of ...... th receptor-induced apoptosis.
@en
P2093
P2860
P356
P1476
c-FLIP mediates resistance of ...... th receptor-induced apoptosis.
@en
P2093
Andreas Lietz
Bernd Dörken
Burkhard Hirsch
Burkhard Wiesner
Franziska Hummel
Franziska Jundt
Harald Stein
Ioannis Anagnostopoulos
Korinna Jöhrens-Leder
Kurt Bommert
P2860
P304
P356
10.1084/JEM.20031080
P407
P577
2004-04-12T00:00:00Z